ISRCTN99559262
Completed
未知
Early signs Monitoring to Prevent relapse and prOmote Wellbeing, Engagement and Recovery: a mixed methods study
HS Greater Glasgow & Clyde0 sites149 target enrollmentStarted: December 21, 2015Last updated:
Overview
- Phase
- 未知
- Status
- Completed
- Sponsor
- HS Greater Glasgow & Clyde
- Enrollment
- 149
Overview
Brief Summary
2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31651400 qualitative study results (added 29/10/2019) 2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31821154 process evaluation protocol (added 11/12/2019) 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31826793 qualitative investigation results (added 13/12/2019) 2020 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31917372 protocol (added 10/01/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35569503/ (added 16/05/2022) 2022 Funder report results in https://pubmed.ncbi.nlm.nih.gov/35639493/ results and plain language summary in Health Technology Assessment (added 08/06/2022)
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Service users of participating CMHT's:
- •1\. Aged 16 years or over
- •2\. In contact with a local community based services
- •3\. Have been admitted to a psychiatric in\-patient service at least once in the previous two years for a relapse of psychosis
- •4\. A diagnosis of schizophrenia spectrum disorder (DSM\-V)
- •5\. Able to provide informed consent as adjudged by the care co\-ordinator or if in doubt the responsible consultant.
- •Carers who are nominated by eligible service users who provide informed consent will also be approached for their inclusion in the study. Service users can also nominate proxy\-carers if they do not have a trusted other (e.g., care co\-ordinator, keyworker, support worker).
Exclusion Criteria
- •Participants who do not meet the inclusion criteria.
Investigators
Similar Trials
Recruiting
Not Applicable
A prospective observational study on relapse prevention factor in electroconvulsive therapySchizophrenia Major depressive disorder Bipolar disorderJPRN-UMIN000036585Department of Neuropsychiatry, Wakayama Medical University60
Recruiting
Not Applicable
Clinical Prognostic Score to Predict Relapse in VLVisceral LeishmaniasisNCT05602610Institute of Tropical Medicine, Belgium741
Recruiting
Not Applicable
Identification of Clinically Significant Markers of ATTRv in Pre-symptomatic Mutation Carriers.AmyloidosisNCT05754099Fondazione Policlinico Universitario Agostino Gemelli IRCCS20
Completed
Not Applicable
Prospective observational study of relapsed and refractory pediatric acute lymphoblastic leukemiaacute lymphoblastic leukemiaJPRN-UMIN000019878Japanese Pediatric Leukemia/Lymphoma Study Group76
Completed
Not Applicable
Factors associated with an underlying somatic cause in children with developmental and/or behavioral disabilityNL-OMON21511Atrium Medical Centre, location Heerlen, the Netherlands200